Aldeyra Therapeutics (ALDX) Acquisitions (2019)
Aldeyra Therapeutics (ALDX) posted Acquisitions of -$22626.0 for Q4 2019, down 132.45% on a QoQ basis from $69728.0 in Q3 2019.
Aldeyra Therapeutics (ALDX) Acquisitions (2019) Analysis & Trends
Aldeyra Therapeutics' Acquisitions history runs 1 years deep, the most recent figure standing at -$22626.0 for Q4 2019.
- Quarterly Acquisitions changed N/A year-over-year to -$22626.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $609464.0 (changed N/A YoY) and the FY2019 annual result came in at $609464.0, changed N/A from the prior year.
- Acquisitions was -$22626.0 for Q4 2019 at Aldeyra Therapeutics, down from $69728.0 in the prior quarter.
- Across five years, Acquisitions topped out at $562362.0 in Q1 2019 and bottomed at -$22626.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Aldeyra Therapeutics | 95.00 Mn | 95.00 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -22,626.00 |
| Sep 30, 2019 | 69,728.00 |
| Mar 31, 2019 | 562,362.00 |